nContact Surgical ncontact.us


Public lists: Medical Devices (6123)

nContact Surgical develops devices for endoscopic treatment of arrhythmias, including atrial fibrillation (AF). The Numeris Coagulation System with VisiTrax is based on the integration of suction, perfusion, and RF energy to ensure the creation of visible, non-conducitve continuos, bi-atrail lesion on the epicardium of a beating heart.

nContact Surgical develops devices for endoscopic treatment of arrhythmias, including atrial fibrillation (AF). The Numeris Coagulation System with VisiTrax is based on the integration of suction, perfusion, and RF energy to ensure the creation of vi...Show all

Company (Acquired)

Phone: 919-466-9810

Fax:

1001 Aviation Parkway
Suite 400
Morrisville, 27560
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
nContact Surgical $47.9M Oct 5, 2015
See all 33 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related nContact Surgical Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors

Competitors

Company Status Description Investors

SenoRx

Irvine, California, United States
AcquiredSenoRx develops surgical products for breast cancer.Login to see details

SurgRx

Redwood City, California, United States
AcquiredSurgRx, Inc. has developed proprietary technology for tissue sealing and cutting, to be used in surgical procedures. The company's products have applications in the gynecology, transplantation, and general surgery markets, whether used endoscopically or in open procedures. The total market potential for these products is in excess of $4 billion. The SurgRx tissue sealing device is deemed safe by the FDA and has been granted 510K regulatory approval.Login to see details
See all 33 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Dissecting cannula and methods of use thereof Mar 25, 2015 Apr 03, 2018 Patent
Articulating cannula access device Oct 08, 2014 Mar 27, 2018 Patent
Vacuum coagulation probes May 30, 2013 Apr 12, 2016 Patent
Subxyphoid epicardial ablation May 13, 2011 Nov 03, 2015 Patent
Vacuum coagulation probes Apr 21, 2006 Apr 07, 2015 Patent
See all 26 patents